Elizabeth Fleming is a senior regulatory affairs professional with extensive experience in global regulatory strategy, product development, and strategic partnerships within the biotech and pharmaceutical industry. They held various roles at Biogen, culminating in the position of Global Head of Regulatory for the biosimilars business unit from 2020 to 2022, and previously served in leadership roles at Allergan from 2009 to 2017. Elizabeth's earlier experience includes positions at Syngenta and i3 Research, where they developed foundational expertise in regulatory affairs. They earned a BSc (Hons) in Chemistry from Heriot-Watt University between 1995 and 1999.
This person is not in the org chart
This person is not in any teams
This person is not in any offices